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Sirtuins (SIRT) are ubiquitous histone and protein deacetylases and a member
of this family, SIRT1, is the best-studied one. Its functions in endothelial cells
encompass branching angiogenesis, activation of endothelial nitric oxide synthase,
regulation of proapoptotic and proinflammatory pathways, among others. Defective
SIRT1 activity has been described in various cardiovascular, renal diseases and in
aging-associated conditions. Therefore, understanding of SIRT1-deficient, endothelial
dysfunctional phenotype has much to offer clinically. Here, we summarize recent studies
by several investigative teams of the characteristics of models of global endothelial
SIRT1 deficiency, the causes of facilitative development of fibrosis in these conditions,
dissect the protein composition of the aberrant secretome of SIRT1-deficient endothelial
cells and present several components of this aberrant secretome that are involved
in fibrogenesis via activation of fibroblasts to myofibroblasts. These include ligands of
Wnt and Notch pathways, as well as proteolytic fragments of glycocalyx core protein,
syndecan-4. The latter finding is crucial for understanding the degradation of glycocalyx
that accompanies SIRT1 deficiency. This spectrum of abnormalities associated with
SIRT1 deficiency in endothelial cells is essential for understanding the origins and
features of endothelial dysfunction in a host of cardiovascular and renal diseases.
Keywords: endothelial secretome, DKK3, Jagged-1, syndecan-4, fibrosis

INTRODUCTION
The broad spectrum of deacetylation targets and dense network of metabolic connections of SIRT1
(Haigis and Guarente, 2006) have contributed to the steadfast interest to the consequences of
its loss or gain of function. Endothelial SIRT1 deficiency is a common companion of various
cardiovascular, metabolic and renal diseases, as well as of aging (Haigis and Guarente, 2006;
Potente et al., 2007; Chen et al., 2012; Maizel et al., 2014; Vasko et al., 2014). All endothelial
functions (deterrent of leukocytes, regulation of permeability and vasomotion, angiogenesis,
platelet adhesion and coagulation) become perturbed in SIRT1 deficiency, thus being responsible
Abbreviations: ADAM17, a disintegrin and metalloproteinase domain 17; CKD, chronic kidney disease; DKK1, Dickkopf1;
DKK3, Dickkopf3; EMT, epithelial-mesenchymal transition; eNOS, endothelial nitric oxide synthase; Flt1, Fms-related
tyrosine kinase; NICD, Notch intracellular domain; RMVEC, renal microvascular endothelial cells; Shh, sonic hedgehog
homolog; SIPS, stress-induced premature vascular senescence; SIRT1, Sirtuin1; SIRT1endo−/−, endothelial knockout SIRT1;
TGFβRIIendo+/−, TGFβ receptor II knockout; UUO, unilateral ureteral obstruction.
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transcriptomic signatures of endothelial cells with the silenced
SIRT1 these authors have discovered phosphoinositide-3-kinase,
Fms-related tyrosine kinase (Flt1), bone morphogenic protein 4,
platelet-derived growth factor beta, TGF-beta-activated kinase
1, matrix metalloproteinase 14, ephrin receptor EphB2 (all
downregulated), sonic hedgehog homolog (Shh), angiopoietin-2,
a disintegrin and metalloproteinase domain 17 (ADAM17) (all
upregulated), among others. They further demonstrated that
SIRT1 deacetylates the forkhead transcription factor Foxo1,
a central negative regulator of blood vessel growth to inhibit
its anti-angiogenic activity (Potente et al., 2007). Impaired
angiogenic sprouting and matrilytic activity has also been noted
by Vasko et al. (2014) by culturing aortic rings from mice
pretreated with a SIRT1-inhibitor. Echocardiographic studies by
Maizel et al. (2014) revealed development of diastolic dysfunction
on the background of myocardial vascular rarefaction in mice
lacking endothelial SIRT1 deacetylase function. Another
characteristic of SIRT1-deficient endothelial cells is their
vulnerability to stress-induced premature vascular senescence
(SIPS). As dysfunctional endothelial cells exhibit increased
lysosomal permeability and leakage of cathepsins, Chen et al.
(2012) demonstrated a cathepsin-induced proteolytic cleavage
of SIRT1 leading to its depletion, and consequently to cell stress
and SIPS.

for global endothelial dysfunction. Below we shall briefly
catalog some sequelae of endothelial SIRT1 deficiency and then
focus on the aberrant profibrogenic secretome of dysfunctional
endothelial cells.
The sirtuin (SIRT) family consists of seven mammalian NADdependent histone deacetylases. SIRT 1 and 2 are expressed in
the nucleus and the cytosol, SIRT 3–5 have been identified as
mitochondrial proteins and SIRT 6 and 7 are solely expressed
in the nucleus (Haigis and Guarente, 2006). It has been
demonstrated that among those family members SIRT1 plays
a critical role in the control of cellular differentiation and
senescence, as well as balancing metabolic pathways, in a broad
variety of tissues (Blander and Guarente, 2004). There is a
remarkably high expression level of SIRT1 in endothelial cells
where it regulates a host of functions, such as activity of
nitric oxide synthase, cell senescence, and autophagy (Borradaile
and Pickering, 2009). In a pioneering study by Potente et al.
(2007) the phenotype of mammalian and zebrafish endothelial
cells expressing SIRT1 with disabled deacetylase domain was
investigated to set a precedent for use of this model system in
future studies. Those studies represent a working model for the
current review.

SIRT1-DEFICIENT ENDOTHELIAL
CELLS – PHENOTYPE

SIRT1 DEFICIENCY PREDISPOSING TO
RENAL FIBROSIS

SIRT1-null mice exhibit high rates of perinatal mortality
and those that survive show developmental deficits, such as
growth retardation, sterility, impaired DNA damage response,
genome instability, impaired lipid metabolism and liver steatosis,
defective immune responses, impaired cognitive functions, and
stem cell differentiation, among other abnormalities, which
collectively hamper their use (Wang et al., 2008; Boily et al., 2010;
Xu et al., 2010; Ou et al., 2011). Therefore, the ways to overcome
this problem include either the use of conditional knockout, or
heterozygote mice, or, more often, cell-specific mutagenesis of
SIRT1. Certainly, a degree of artificiality could be introduced
by the cell-specific knockout, which presumably leaves all other
cells intact. As we shall see from the following discussion, this is
not the case: endothelial deletion of SIRT1 deacetylase-encoding
domain profoundly affects neighboring cells and tissues.
One of the dire characteristics of SIRT1-deficient endothelial
cells is the reduced endothelium-dependent vasorelaxation.
Functional SIRT1 deacetylates the endothelial nitric oxide
synthase (eNOS) on lysines 496 and 506 in the calmodulinbinding domain of eNOS. With the deacetylation of eNOS its
activity is increased leading to elevated levels of bioavailable
endothelial nitric oxide (Mattagajasingh et al., 2007). Endothelial
SIRT1-deficiency is also characterized by microvascular
rarefaction, which can already be seen at a basal state without
any endogenous or exogenous insult. The level of microvascular
rarefaction increases significantly after damage (Kida et al.,
2016). Potente et al. (2007) have shown that endothelial SIRT1deficiency impedes sprouting angiogenesis and branching
morphogenesis with simultaneous down-regulation of genes
involved in blood vessel growth and vascular remodeling. Among
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The described characteristics and spectrum of functions explain
the association of endothelial SIRT1 deficiency with impaired
vasoreactivity and increased numbers of prematurely senescent
endothelial cells. However, mice with endothelial SIRT1deficiency have also been shown to have a higher susceptibility
to develop fibrosis. Vasko et al. (2014) have used genetically
engineered mice with a deletion of the exon 4 (encoding the
deacetylase domain) in endothelial SIRT1 (hereafter abbreviated
as SIRT1endo −/−) and have demonstrated that those mice
not only develop vasculopathy and premature senescence, but
also tubulointerstitial fibrosis at an early age. One of the
mechanistic links presented is the observation that endothelial
SIRT1-deficient mice have lower expression of the master matrix
metalloproteinase, MMP-14. Lower MMP-14 leads to impaired
degradation of deposited matrix proteins, and as a result of
reduced matrilytic activity, endothelial cells lose their ability to
navigate within the interstitial matrix and recover metabolism
and regeneration of the affected organs (Oh et al., 2001; Riggins
et al., 2010; Vasko et al., 2014). Pharmacologic stimulation of
MMP-14 expression, using a SIRT1-independent strategy, is
able to lower tubulointerstitial fibrosis in SIRT1endo −/− mice,
thus confirming the role of MMP-14 in the development of
tubulointerstitial fibrosis in those mice (Vasko et al., 2014). Of
note, a similar downregulation of MMP-14 in SIRT1 deficiency
has been noted by Potente et al. (2007).
Another mechanistic link on how SIRT1 deficiency leads to
renal fibrosis has been proposed by Huang et al. Depletion of
SIRT1 increases the acetylation level of Smad3 and consequently
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of RMVEC from control wild-type, SIRT1endo −/− and
TGFβRIIendo +/− mice using unbiased, non-targeted MS/MS,
after they were exposed to a vehicle or TGFβ for 48 hours
(Lipphardt et al., 2017). 332 non-redundant proteins, which
belong to diverse categories, were detected. Out of the 332
proteins, those secreted only by Sirt1endo −/− vis-a-vis
TGFβRIIendo +/− are of special interest, since they could
theoretically be responsible for the pro- and anti-fibrogenic
phenotype of the respective mice. Some of these findings are
presented in Table 1. Detailed list of identified protein in
the endothelial secretome can be found in Supplementary
Table 1.

increases its transcriptional activity following activation by
TGF-β1. On the other hand, TGF-β1-induced extracellular
matrix expression was attenuated by elevated levels of SIRT1,
supporting the idea of protective role of SIRT1 in the
development of renal fibrosis due to its action on TGF-β/Smad3
signaling (Huang et al., 2014).

THE SECRETOME OF SIRT1-DEFICIENT
RENAL MICROVASCULAR
ENDOTHELIAL CELLS
Genetic manipulation of relevant gene expression in endothelial
cells has brought about intriguing findings. On the one hand,
studies performed by Xavier et al. demonstrated that mice with
endothelium-specific heterozygous TGFβ receptor II knockout
(TGFβRIIendo +/−) are protected against tubulointerstitial
fibrosis (induced in two different models, unilateral ureteral
obstruction (UUO) and chronic phase of folic acid nephropathy),
have a better preservation of renal microvasculature, show a
better renal blood flow, and have a less profound tissue hypoxia
than TGFβRIIendo +/+ control mice. TGFβRIIendo +/− mice
also show suppressed endothelial-to-mesenchymal transition in
these fibrogenic models (Xavier et al., 2015). On the other hand,
as mentioned above, SIRT1endo −/− mice develop exaggerated
fibrosis under basal conditions and following UUO and folic acid
nephropathy (Vasko et al., 2014). The finding that SIRT1endo −/−
mice are more susceptible to development of tubulointerstitial
fibrosis, in contrast to TGFβRIIendo +/− mice that are protected
against it, supports the concept that distinct messages from the
endothelium are instructive for fibroblasts. It also prompted us
to compare endothelial secretomes, as the only distantly acting
variable with the potential to explain the distinct end-results.
A fraction of proteins, which are secreted to the extracellular
compartment is defined as the cell secretome. The secretome is
very specific and depends on the types of cells and tissues and the
secretomic response differs based on the physiologic states and
pathologic conditions.
The progression of tissue fibrosis going side by side with
microvascular rarefaction still does not have a molecular
explanation. One possible way to explain multiple confirmatory
observations is by invoking the communication between
endothelial cells and fibroblasts via secretory products. In
order to analyze proteomic signatures of secretory products of
renal microvascular endothelial cells (RMVEC), we obtained
and analyzed conditioned media of high-purity populations

AGONISTS OF NOTCH AND Wnt
PATHWAYS IN THE SECRETOME
Intriguingly, Jagged1 (a ligand of the Notch pathway) and
Dickkopf3 (DKK3) (a putative ligand of the Wnt pathway) were
found among the proteins exclusively secreted by Sirt1endo −/−
mice upon stimulation with TGFβ. Both pathways previously
have been implicated in the development of fibrosis, are
mechanistically interconnected (see Figure 1), Notch signaling
is SIRT1-dependent [it deacetylates Notch intracellular domain,
NICD, and targets it to proteasomal degradation (Guarani et al.,
2011)] and therefore warranted our further investigation. Besides
the important roles in carcinogenesis, heart function and bone
metabolism, among others, Wnt signaling and the Dickkopf
family proteins have a vast impact during the embryogenesis of
the kidney and exert a key role in the development or progression
of chronic kidney disease (CKD) and kidney fibrosis. It has been
shown that Wnt proteins can act on unstimulated mesenchymal
cells and program them to differentiate into epithelial cells
(Boyle et al., 2011). Indeed, Wnt-responsive cells have been
found in the renal medulla and renal tubules of adult mice
and have most likely the capability to act as progenitor or stem
cells (Oliver et al., 2004; Rinkevich et al., 2014). The fact that
many Wnt proteins are upregulated after application of acute
ischaemia-reperfusion injury, is consistent with their ability to
promote cell regeneration (Lin et al., 2010; Kawakami et al.,
2013).
Regarding the Wnt pathway in the development of kidney
fibrosis, 16 out of 19 Wnt proteins and 8 out of 10 Frizzled
receptors have been found to be elevated in renal tubular cells
in kidney fibrosis due to UUO (He et al., 2009). Zhou et al. (2012,
2013) showed that genetic overexpression of active β-catenin in

TABLE 1 | Details of three selected proteins of the secretome of Sirt1–/– RMVEC.
Protein name

Gene name

Accession number

Molecular weight (kDa)

Sequence coverage (%)

Unique peptides

Dickkopf-related protein 3

DKK3

Q9QUN9

38.4

24

8

Jagged-1

Jag1

Q9QXX0

134.2

17

17

Syndecan-4

Sdc4

O35988

21.5

15

4

A partial list of proteins of interest identified as secreted at a high level in Sirt1−/− RMVEC treated with TGFß-1 compared to TGFR2+/− RMVEC subjected to the similar
treatment. Gene name, calculated molecular weight and accession number are given. Additional MS/MS information, e.g., the number of unique peptides that were
sequenced through MS/MS and the achieved sequence coverage are provided.
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FIGURE 1 | Fibrogenic secretome pathways implicated in the development of fibrosis and their dependence on SIRT1. Secretomic findings of DKK3 and Jagged1
are shown in red. DKK3 induces the Wnt pathway activating the frizzled receptor with its co-receptors LRP5/6. Further activation of the GSK3β leads to β-catenin
nuclear translocation and therefore inducing the TCF/LEF family, target genes of the Wnt pathway. Jagged1 activates the Notch pathway with further NICD nuclear
translocation and activation of Hes and Hey genes. Lack of SIRT1 leads to less degradation of NICD, which also leads to more β-catenin nuclear translocation,
combining the Wnt and Notch pathway. Abbreviations: Wnt, wingless-related integration site – a signaling glycoprotein; Fz, frizzled receptor – a family of G
protein-coupled receptor proteins serving as Wnt receptors; Disheveled – a family of cytoplasmic phosphoproteins downstream of frizzled receptors, which are
involved in canonical and non-canonical Wnt signaling; NICD, notch intracellular domain; GSK3β, glycogen synthase kinase 3 beta; TCF/LEF family is a group of
transcription factors involved in the Wnt signaling pathway; Hes, hairy and enhancer of split transcription factor protein; and Hey hairy/enhancer-of-split related
transcription factor protein.

existence of rheostat-like relations between DKK1 and DKK3.
Our endothelial findings in conjunction with the existing data on
Wnt and DKK3 secretion from stressed renal tubular epithelial
cells (Federico et al., 2016; Maarouf et al., 2016) lead us to
assume that the renal microvascular endothelium serves as a finetuned modulator of Wnt agonists and antagonists reaching renal
fibroblasts.
The Notch pathway has been established to be of significant
importance during kidney development (Sirin and Susztak,
2012). For instance, human kidney developmental abnormalities
have been observed due to mutations of Jagged1, a Notch ligand,
and Notch2, a Notch receptor (Penton et al., 2012). Upon
completion of developmental programs, the resident stem cell
population harbors the most active Notch signaling among adult
organs.
Regarding the impact of Notch signaling in the development
of kidney fibrosis it is crucial to mention that the transcript
and protein levels of members of the Notch pathway are highly
elevated in patients with CKD, such as diabetic nephropathy,
lupus nephritis and focal segmental glomerulosclerosis. It has
been demonstrated also that Notch1 expression in renal tubules
is associated with tubulointerstitial fibrosis and decreased kidney
function in patients with CKD (Murea et al., 2010). Supporting
the findings of the above mentioned study, Bielesz et al. described
increased epithelial cell proliferation and tubular epithelial
dedifferentiation after induced cell-specific expression of cleaved
Notch1 in tubular epithelial cells, concluding that the expression
of Notch receptors in tubular epithelial cells is capable of inducing
EMT. They further investigated the genetic deletion of Rbpj, the
central transcriptional mediator of Notch signaling in proximal
tubular epithelial cells, and found reduced tubulointerstitial

tubular cells induces kidney fibrosis and epithelial-mesenchymal
transition (EMT).
Among the DKK protein family, the role of DKK3 and its
interactions with the Wnt pathway is controversial. Dickkopf1
(DKK1) is a well-studied Wnt antagonist and He et al. (2009)
demonstrated that the injection of a vector encoding for DKK1
reduced tubulointerstitial fibrosis and β-catenin accumulation.
DKK3, on the other hand, has been shown to act as a pro-survival
signal by positively modulating the Wnt pathway (Nakamura
and Hackam, 2010). DKK3 also has been described as a cytokine
capable of inducing stem cell differentiation (Wang et al., 2015),
as a tumor suppressor (Veeck and Dahl, 2012) and as an
inhibitor of VEGFR2/Akt/mTOR signaling (Kim et al., 2015).
Recently, DKK3 was found to be a tubular epithelia-derived
mediator of kidney fibrosis with decreased tubular atrophy
and interstitial matrix accumulation after blockade of DKK3
in different mouse models of kidney fibrosis (Federico et al.,
2016). Similarly, proximal tubules with tamoxifen-induced Wnt1
expression have profound interstitial myofibroblast activation
and proliferation and increased extracellular matrix proteins
production (Maarouf et al., 2016). We showed that DKK3 is
able to convert fibroblasts into myofibroblasts with DKK3 being
secreted by SIRT1 deficient endothelial cells (Lipphardt et al.,
2018a). We also investigated the relations between DKK1 and
DKK3 and learned that DKK3 is only able to activate fibroblasts
to acquire myofibroblastic phenotype at low levels of DKK1.
With escalating levels of ambient DKK1 the conversion of
fibroblasts into myofibroblasts is averted. Those observations
would argue that cells closest to dysfunctional endothelial cells,
for example pericytes, are most impacted by DKK3 secreted
from dysfunctional endothelium. The data also indicate the
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termed, the “third pathway” of fibrogenesis (Figure 2) (Lipphardt
et al., 2017).

fibrosis following folic acid nephropathy (Bielesz et al., 2010).
A different approach in deleting Notch3 showed protection
against tubulointerstitial fibrosis with decreased numbers of
αSMA positive cells following UUO (Djudjaj et al., 2012).
Among the ligands for the Notch pathway we found
Jagged1, which was exclusively secreted by SIRT1-deficient
endothelial cells after TGFβ stimulation. 2-D culture studies
also showed higher endothelial-mesenchymal transition after
exposure to Jagged1 or Jagged2, especially in combination with
TGFβ1 (unpublished data). Additional experiments confirmed
the activation of the Notch pathway by demonstrating NICD
(intracellular domain of the Notch protein) and αSMA-positive
RMVEC (unpublished data). In order to investigate the combined
effects of Jagged1 on renal fibroblasts and RMVEC we used a coculture system utilizing microfluidic devices based on previously
published protocols (Kim et al., 2013). Once the RMVEC and
the renal fibroblasts were exposed to Jagged1 we observed a
decrease in total vessel length, reduced number of bifurcations
along with reduced percentage area occupied by capillarylike structures (unpublished data). We also detected a greater
extent of endothelial-mesenchymal transition and fibroblastto-myofibroblast conversion, as judged by the appearance of
α-SMA-GFP fluorescence. Those results are in accord with
our previous study showing that endothelial SIRT1-deficiency
leads to enhanced microvascular rarefaction and fibrosis through
activation of the Notch pathway (Kida et al., 2016). These
findings, however, should be interpreted with caution, as Notch
activating ligands are usually presented in immobilized form
of cis- or trans-position. Kopan and Ilagan (2009) specifically
discuss potential contribution of diffusible ligands and propose
that they could be immobilized by extracellular matrix proteins
“to provide sufficient leverage to unfold/dissociate the negative
regulatory region and activate Notch.”
In conclusion, it appears that microenvironmental signals
deriving from dysfunctional endothelial cells mediate the fate
of (myo)fibroblasts. Endothelial cells deficient in SIRT1 secrete
DKK3 and Jagged1 and induce the conversion of fibroblasts
into myofibroblasts and contribute to the dysfunctional
endothelium-dependent facilitation of tissue fibrosis, which we

AUTOCRINE EFFECTS OF
ENDOTHELIAL SECRETOME
Having demonstrated the effects of DKK3 and Jagged1 secreted
from dysfunctional endothelial cells exerting paracrine effects
on renal fibroblasts, it was only plausible to expect their
autocrine effects. In experiments on DKK3 application to
cultured RMVEC we found that DKK3 significantly increased
the amount of RMVEC undergoing endothelial-mesenchymal
transition (Lipphardt et al., 2018a). We also showed that
RMVEC cultured on matrigel exhibited reduced total vessel
length, percentage area occupied by capillary-like structures,
and limited number of bifurcations after treatment with DKK3
(Lipphardt et al., 2018a). As mentioned earlier, Jagged1 is
also capable of inducing endothelial-mesenchymal transition
and impairing angiogenesis. Dysfunctional endothelial cells not
only contribute to fibrogenesis by sending microenvironmental
signals to neighboring cells but also by self-reprogramming
leading to enhanced endothelial-mesenchymal transition.

ENDOTHELIAL SECRETOME AND
GLYCOCALYX
The endothelial glycocalyx consists of hyaluronic acid cords,
heparan sulfate chains and a mixture of dermatan, keratan, and
chondroitin sulfates, which give the endothelial glycocalyx a
net negative charge (Reitsma et al., 2007). The scaffold of the
endothelial glycocalyx contains two families of proteoglycans:
syndecans 1-4 and glypicans 1-6. The endothelial glycocalyx
mediates the interaction between extracellular molecules,
circulating cells and endothelial cells, regulates mechanosensing
and vasorelaxation, coagulation, and serves as a passive barrier
to water and solutes. The endothelial glycocalyx has a high
vulnerability and is degraded in the presence of various stressors,

FIGURE 2 | Cross talk between dysfunctional endothelial cells, pericytes, epithelial cells, and (myo)fibroblasts through DKK1/DKK3/Wnt/Jagged1 in the kidney.
Schematic presentation of the interaction of different cell lines mediated by agonists of the Wnt- and Notch pathway. Dotted line – deduced conclusion. Dashed
line – based on the published literature (Federico et al., 2016; Maarouf et al., 2016).
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components, which are capable of activating fibroblasts and
promoting tissue fibrosis. Furthermore, studies of the secretome
of SIRT1-deficient cells revealed that a key component of
endothelial glycocalyx is shed, its fragment is pro-fibrogenic,
whereas the aberrant composition of endothelial glycocalyx
could further exacerbate endothelial dysfunction. These findings
provide added support to the therapeutic interventions to correct
SIRT1 expression and activity.

such as endotoxins, ischemia/hypoxia/reperfusion, or oxidative
stress. We observed that endothelial SIRT1-deficiency causes a
decline in the endothelial glycocalyx already at a basal state,
which is due to a higher level of shedding of syndecan-4, the
main proteoglycan of the endothelial glycocalyx (Lipphardt et al.,
2018b). We found this protein to be exclusively secreted by
SIRT1-deficient endothelial cells upon stimulation with TGFβ
was syndecan-4. We established the link between enhanced
NF-κB signaling in SIRT1-deficient endothelial cells, which
consequently leads to an elevation in syndecan-4 synthesis. This
increase in syndecan-4 synthesis is driven by the presence of
a NF-κB response element in the promoter region of Synd4
(Strand et al., 2013; Lipphardt et al., 2018b). In addition to
the enhanced NF-κB signaling in SIRT1-deficient endothelial
cells and therefore elevated syndecan-4 synthesis, we also
showed an increased oxidative stress in SIRT1-deficient RMVEC.
Increased oxidative stress may explain the activation of the major
sheddase ADAM17 (its activity is regulated by 2 vicinal cysteine
clusters), which leads to an enhanced shedding of syndecan-4,
consequently leading to the decline of the endothelial glycocalyx
(Wang et al., 2009; Lipphardt et al., 2018b). Remarkably, the
shed ectodomains of Synd4 exert pro-fibrogenic effect, as we
have shown by injecting ectodomain protein subcapsularly to
the intact kidneys and detecting the appearance of picrosirius
red staining (Lipphardt et al., 2018b). Hence, the excessive
degradation of the endothelial glycocalyx can be viewed as
another effect of the secretome of dysfunctional endothelial
cells and may explain in part the phenotype of SIRT1-deficient
endothelial cells discussed earlier.
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